Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. JATT
JATT logo

JATT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
10.725
Open
10.000
VWAP
10.41
Vol
279.38K
Mkt Cap
--
Low
9.990
Amount
2.91M
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Events Timeline

No data

No data

News

renaissancecapital
8.5
04-19renaissancecapital
PinnedJATT II Acquisition Raises $60 Million for Biotech Focus
  • Funding Details: JATT II Acquisition successfully raised $60 million by offering 6 million shares at $10 each, reflecting ongoing market interest in the biotech and life sciences sectors.
  • Management Background: Led by CEO and Chairman Someit Sidhu, who has founded and managed several healthcare companies, including his recent role as CEO of Khanda Therapeutics, indicating strong industry expertise.
  • Investment Focus: The SPAC plans to target healthcare and related businesses, with a primary emphasis on biotechnology and broader life sciences, aiming to capitalize on market growth potential.
  • Transaction Arrangement: The company will trade on Nasdaq under the symbol JATT, with Guggenheim Securities acting as the sole bookrunner for the deal, ensuring professionalism and smooth execution of the transaction.
Wall Street analysts forecast JATT stock price to rise
0 Analyst Rating
Wall Street analysts forecast JATT stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for Zura Bio Ltd (JATT.O) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess Zura Bio Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
Current PE
NaN
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
Current EV/EBITDA
NaN
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
Current PS
NaN
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding JATT

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Zura Bio Ltd (JATT) stock price today?

The current price of JATT is 10.5 USD — it has increased 5

What is Zura Bio Ltd (JATT)'s business?

What is the price predicton of JATT Stock?

Wall Street analysts forecast JATT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for JATT is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Zura Bio Ltd (JATT)'s revenue for the last quarter?

Zura Bio Ltd revenue for the last quarter amounts to NaN USD, decreased

What is Zura Bio Ltd (JATT)'s earnings per share (EPS) for the last quarter?

Zura Bio Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does Zura Bio Ltd (JATT). have?

Zura Bio Ltd (JATT) has 0 emplpoyees as of April 20 2026.

What is Zura Bio Ltd (JATT) market cap?

Today JATT has the market capitalization of 0.00 USD.